Patents by Inventor Julien Vibert

Julien Vibert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapy Targeting Tumor Neoantigenic Peptides
    Publication number: 20220401539
    Abstract: The present disclosure relates to a tumor specific neoantigenic peptide, wherein said peptide (i) is encoded by a part of an (ORF) sequence from an unannotated transcript which transcription is positively regulated by an aberrant fusion protein, and (ii) is expressed at a higher level or frequency in a sample from said tumor compared to normal tissue sample. The present disclosure also relates to vaccine or immunogenic composition, antibodies and immune cells derived thereof and their use in therapy of cancer.
    Type: Application
    Filed: October 22, 2020
    Publication date: December 22, 2022
    Applicants: Institut Curie, Institut National de la Santé et de la Recherche Médicale
    Inventors: Olivier Delattre, Olivier Saulnier, Joshua Waterfall, Céline Collin, Julien Vibert, Maud Gautier